Cargando…
Clinical application of plasma mitochondrial DNA content in patients with lung cancer
Alterations of mitochondrial DNA (mtDNA) have been identified in several types of solid tumor. However, to the best of our knowledge, the clinical significance of plasma mtDNA content in lung cancer remains unknown. Thus, the current study explored the diagnostic and prognostic value of plasma mtDNA...
Autores principales: | Chen, Jianhua, Zhang, Lemeng, Yu, Xun, Zhou, Hui, Luo, Yongzhong, Wang, Wei, Wang, Lijing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256833/ https://www.ncbi.nlm.nih.gov/pubmed/30546441 http://dx.doi.org/10.3892/ol.2018.9515 |
Ejemplares similares
-
Effectiveness of Treatment with Endostatin in Combination with Emcitabine, Carboplatin, and Gemcitabine in Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Study
por: Yu, Xun, et al.
Publicado: (2018) -
Interferon regulatory factor-1 regulates cisplatin-induced apoptosis and autophagy in A549 lung cancer cells
por: Zhang, Lemeng, et al.
Publicado: (2022) -
A Novel Risk Score Model of Lactate Metabolism for Predicting over Survival and Immune Signature in Lung Adenocarcinoma
por: Jiang, Zhou, et al.
Publicado: (2022) -
Efficacy and Safety of Afatinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with EGFR Mutations: A Meta-Analysis of Real-World Evidence
por: Zhang, Lemeng, et al.
Publicado: (2021) -
Multiple microarray analyses identify key genes associated with the development of Non-Small Cell Lung Cancer from Chronic Obstructive Pulmonary Disease
por: Zhang, Lemeng, et al.
Publicado: (2021)